Jeffrey Stambough
Concepts (248)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthroplasty, Replacement, Hip | 50 | 2024 | 260 | 15.120 |
Why?
| Arthroplasty, Replacement, Knee | 40 | 2024 | 280 | 13.080 |
Why?
| Prosthesis-Related Infections | 10 | 2024 | 106 | 5.270 |
Why?
| Knee Prosthesis | 7 | 2023 | 50 | 3.360 |
Why?
| Hip Prosthesis | 9 | 2022 | 71 | 2.850 |
Why?
| Anesthesia, General | 4 | 2024 | 90 | 2.340 |
Why?
| Patient Readmission | 10 | 2024 | 222 | 2.340 |
Why?
| Reoperation | 16 | 2024 | 453 | 2.250 |
Why?
| Osteoarthritis, Knee | 6 | 2023 | 88 | 2.180 |
Why?
| Retrospective Studies | 40 | 2024 | 6123 | 2.010 |
Why?
| Postoperative Complications | 11 | 2024 | 1018 | 1.980 |
Why?
| Arthritis, Infectious | 4 | 2023 | 46 | 1.870 |
Why?
| Knee Joint | 16 | 2023 | 161 | 1.810 |
Why?
| Orthopedics | 5 | 2022 | 50 | 1.810 |
Why?
| Arthroplasty | 5 | 2023 | 28 | 1.760 |
Why?
| Humans | 89 | 2024 | 49898 | 1.570 |
Why?
| Length of Stay | 10 | 2024 | 624 | 1.530 |
Why?
| Anti-Bacterial Agents | 5 | 2024 | 742 | 1.410 |
Why?
| Pneumonia, Viral | 4 | 2020 | 170 | 1.390 |
Why?
| Coronavirus Infections | 4 | 2020 | 179 | 1.370 |
Why?
| Hospitals | 6 | 2024 | 172 | 1.290 |
Why?
| Femoral Fractures | 3 | 2023 | 39 | 1.240 |
Why?
| Opioid-Related Disorders | 5 | 2024 | 387 | 1.170 |
Why?
| Osteoarthritis, Hip | 3 | 2016 | 25 | 1.140 |
Why?
| Patient Discharge | 6 | 2022 | 318 | 1.100 |
Why?
| Polyethylene | 5 | 2020 | 18 | 1.080 |
Why?
| Joint Instability | 4 | 2022 | 40 | 1.080 |
Why?
| Hip Fractures | 2 | 2023 | 45 | 1.040 |
Why?
| Aged | 27 | 2024 | 9447 | 1.040 |
Why?
| Medicare | 10 | 2024 | 245 | 1.000 |
Why?
| Debridement | 2 | 2024 | 44 | 0.990 |
Why?
| Anesthesia, Spinal | 2 | 2022 | 16 | 0.990 |
Why?
| Perioperative Care | 2 | 2016 | 42 | 0.980 |
Why?
| Registries | 4 | 2024 | 522 | 0.960 |
Why?
| Pandemics | 6 | 2022 | 566 | 0.930 |
Why?
| Treatment Outcome | 16 | 2024 | 5176 | 0.930 |
Why?
| United States | 20 | 2024 | 4878 | 0.930 |
Why?
| Femur | 5 | 2023 | 130 | 0.920 |
Why?
| Femur Head | 4 | 2019 | 25 | 0.920 |
Why?
| Osteotomy | 3 | 2018 | 32 | 0.870 |
Why?
| Pain, Postoperative | 8 | 2024 | 157 | 0.870 |
Why?
| Femoral Neck Fractures | 2 | 2022 | 8 | 0.870 |
Why?
| Knee Injuries | 1 | 2023 | 27 | 0.850 |
Why?
| Anemia | 1 | 2023 | 66 | 0.850 |
Why?
| Prosthesis Failure | 5 | 2020 | 108 | 0.840 |
Why?
| Analgesics, Opioid | 8 | 2024 | 554 | 0.830 |
Why?
| Bariatric Surgery | 1 | 2023 | 41 | 0.820 |
Why?
| Osteoarthritis | 1 | 2023 | 61 | 0.820 |
Why?
| Obesity, Morbid | 1 | 2023 | 74 | 0.800 |
Why?
| Male | 29 | 2024 | 25437 | 0.780 |
Why?
| Middle Aged | 23 | 2024 | 12285 | 0.760 |
Why?
| Female | 30 | 2024 | 26560 | 0.740 |
Why?
| Anti-Infective Agents, Local | 1 | 2021 | 27 | 0.720 |
Why?
| Prosthesis Design | 9 | 2023 | 240 | 0.710 |
Why?
| Aged, 80 and over | 10 | 2024 | 3136 | 0.700 |
Why?
| Acetabulum | 4 | 2020 | 38 | 0.690 |
Why?
| Narcotics | 1 | 2020 | 108 | 0.690 |
Why?
| Diabetes Mellitus | 1 | 2023 | 279 | 0.680 |
Why?
| Patient Satisfaction | 2 | 2022 | 278 | 0.680 |
Why?
| Skilled Nursing Facilities | 2 | 2022 | 9 | 0.670 |
Why?
| Arthralgia | 2 | 2022 | 43 | 0.670 |
Why?
| Medicaid | 2 | 2019 | 255 | 0.670 |
Why?
| Range of Motion, Articular | 6 | 2023 | 108 | 0.660 |
Why?
| Societies, Medical | 2 | 2023 | 177 | 0.650 |
Why?
| Blood Sedimentation | 1 | 2019 | 13 | 0.650 |
Why?
| Bone Anteversion | 1 | 2018 | 2 | 0.640 |
Why?
| Bone Nails | 1 | 2018 | 10 | 0.640 |
Why?
| Risk Factors | 9 | 2023 | 3604 | 0.610 |
Why?
| Time-to-Treatment | 1 | 2019 | 70 | 0.600 |
Why?
| C-Reactive Protein | 1 | 2019 | 143 | 0.600 |
Why?
| Mupirocin | 1 | 2016 | 4 | 0.550 |
Why?
| Chlorhexidine | 1 | 2016 | 11 | 0.550 |
Why?
| Quadriceps Muscle | 3 | 2022 | 46 | 0.530 |
Why?
| Hip Joint | 2 | 2015 | 57 | 0.530 |
Why?
| Practice Guidelines as Topic | 1 | 2019 | 458 | 0.520 |
Why?
| Adult | 17 | 2024 | 13346 | 0.520 |
Why?
| Spinal Stenosis | 2 | 2010 | 11 | 0.520 |
Why?
| Surgical Wound Infection | 1 | 2016 | 114 | 0.500 |
Why?
| Pelvic Bones | 1 | 2015 | 11 | 0.490 |
Why?
| Prospective Studies | 6 | 2021 | 2345 | 0.490 |
Why?
| Clinical Protocols | 1 | 2015 | 109 | 0.470 |
Why?
| Patient Care Team | 1 | 2016 | 259 | 0.450 |
Why?
| Bone Transplantation | 2 | 2013 | 46 | 0.450 |
Why?
| Curettage | 1 | 2013 | 12 | 0.440 |
Why?
| Time Factors | 6 | 2020 | 2891 | 0.440 |
Why?
| Humerus | 1 | 2013 | 18 | 0.440 |
Why?
| Capillaries | 1 | 2013 | 50 | 0.430 |
Why?
| Decompression, Surgical | 1 | 2013 | 49 | 0.430 |
Why?
| Tibia | 3 | 2023 | 115 | 0.420 |
Why?
| Periprosthetic Fractures | 2 | 2023 | 11 | 0.410 |
Why?
| Osteocytes | 2 | 2024 | 214 | 0.370 |
Why?
| Lumbar Vertebrae | 2 | 2022 | 97 | 0.370 |
Why?
| Quality Indicators, Health Care | 2 | 2024 | 86 | 0.360 |
Why?
| Pain | 6 | 2024 | 374 | 0.360 |
Why?
| Intervertebral Disc Degeneration | 1 | 2010 | 4 | 0.350 |
Why?
| Radiography | 3 | 2019 | 485 | 0.350 |
Why?
| Muscle Strength | 2 | 2022 | 125 | 0.340 |
Why?
| Bone Morphogenetic Proteins | 1 | 2010 | 56 | 0.330 |
Why?
| Follow-Up Studies | 5 | 2019 | 2175 | 0.330 |
Why?
| Pain Measurement | 3 | 2024 | 246 | 0.330 |
Why?
| Transforming Growth Factor beta | 1 | 2010 | 136 | 0.320 |
Why?
| Spinal Fusion | 1 | 2010 | 69 | 0.320 |
Why?
| Recombinant Proteins | 1 | 2010 | 482 | 0.310 |
Why?
| Incidence | 2 | 2024 | 986 | 0.300 |
Why?
| Adolescent | 6 | 2019 | 6414 | 0.280 |
Why?
| Osteolysis | 2 | 2018 | 75 | 0.270 |
Why?
| Tertiary Care Centers | 2 | 2023 | 76 | 0.260 |
Why?
| Referral and Consultation | 2 | 2020 | 284 | 0.260 |
Why?
| Young Adult | 5 | 2019 | 4029 | 0.240 |
Why?
| Single-Cell Analysis | 1 | 2024 | 63 | 0.230 |
Why?
| Prospective Payment System | 1 | 2024 | 5 | 0.230 |
Why?
| Leg Injuries | 1 | 2024 | 12 | 0.230 |
Why?
| Tibial Fractures | 1 | 2024 | 30 | 0.230 |
Why?
| Endrin | 1 | 2023 | 3 | 0.230 |
Why?
| Nerve Block | 1 | 2024 | 39 | 0.230 |
Why?
| Aftercare | 2 | 2022 | 74 | 0.220 |
Why?
| Polyethylenes | 1 | 2023 | 13 | 0.220 |
Why?
| International Classification of Diseases | 1 | 2023 | 63 | 0.210 |
Why?
| Systemic Inflammatory Response Syndrome | 1 | 2023 | 53 | 0.210 |
Why?
| Transplantation, Homologous | 1 | 2023 | 140 | 0.210 |
Why?
| Mechanotransduction, Cellular | 1 | 2023 | 36 | 0.210 |
Why?
| Bone Neoplasms | 1 | 2024 | 178 | 0.210 |
Why?
| Crowdsourcing | 1 | 2022 | 8 | 0.200 |
Why?
| Lordosis | 1 | 2022 | 4 | 0.200 |
Why?
| Bone Diseases, Metabolic | 1 | 2023 | 73 | 0.200 |
Why?
| Osteonecrosis | 1 | 2022 | 34 | 0.200 |
Why?
| Kyphosis | 1 | 2022 | 15 | 0.200 |
Why?
| Quality of Life | 3 | 2022 | 837 | 0.200 |
Why?
| Disability Evaluation | 2 | 2019 | 88 | 0.190 |
Why?
| Cost of Illness | 1 | 2022 | 113 | 0.190 |
Why?
| Metal-on-Metal Joint Prostheses | 1 | 2021 | 5 | 0.190 |
Why?
| Leg | 1 | 2022 | 123 | 0.190 |
Why?
| Hospitalization | 2 | 2023 | 663 | 0.190 |
Why?
| Anemia, Sickle Cell | 1 | 2022 | 94 | 0.190 |
Why?
| alpha-Defensins | 1 | 2021 | 3 | 0.190 |
Why?
| Bone Resorption | 1 | 2023 | 297 | 0.180 |
Why?
| Therapeutic Irrigation | 1 | 2021 | 27 | 0.180 |
Why?
| Cohort Studies | 3 | 2022 | 1403 | 0.180 |
Why?
| Weight Loss | 1 | 2023 | 241 | 0.180 |
Why?
| North America | 1 | 2020 | 65 | 0.180 |
Why?
| Polyradiculopathy | 1 | 2000 | 4 | 0.180 |
Why?
| Salvage Therapy | 1 | 2021 | 136 | 0.180 |
Why?
| Chromium | 2 | 2021 | 6 | 0.180 |
Why?
| Cobalt | 2 | 2021 | 16 | 0.170 |
Why?
| Workload | 1 | 2020 | 43 | 0.170 |
Why?
| Anesthesia, Epidural | 1 | 2000 | 25 | 0.170 |
Why?
| Health Planning Guidelines | 1 | 2019 | 13 | 0.160 |
Why?
| Comorbidity | 2 | 2018 | 610 | 0.160 |
Why?
| Hemiarthroplasty | 1 | 2019 | 7 | 0.160 |
Why?
| Leadership | 1 | 2020 | 101 | 0.160 |
Why?
| New York City | 1 | 2019 | 26 | 0.160 |
Why?
| Social Media | 1 | 2021 | 98 | 0.160 |
Why?
| Insurance, Health, Reimbursement | 1 | 2019 | 24 | 0.160 |
Why?
| North Carolina | 1 | 2019 | 53 | 0.160 |
Why?
| Physical Examination | 1 | 2019 | 93 | 0.160 |
Why?
| Sepsis | 1 | 2021 | 220 | 0.160 |
Why?
| Rotation | 1 | 2018 | 44 | 0.160 |
Why?
| Electronic Health Records | 1 | 2021 | 209 | 0.160 |
Why?
| Ambulatory Surgical Procedures | 1 | 2019 | 51 | 0.160 |
Why?
| Health Resources | 1 | 2019 | 74 | 0.160 |
Why?
| Rural Population | 1 | 2023 | 549 | 0.150 |
Why?
| Insurance Claim Review | 1 | 2018 | 36 | 0.150 |
Why?
| Recovery of Function | 2 | 2016 | 187 | 0.150 |
Why?
| Insurance, Health | 1 | 2019 | 131 | 0.150 |
Why?
| Joint Diseases | 1 | 2018 | 41 | 0.150 |
Why?
| Imaging, Three-Dimensional | 2 | 2016 | 152 | 0.150 |
Why?
| Administration, Intranasal | 1 | 2016 | 29 | 0.140 |
Why?
| Missouri | 1 | 2016 | 64 | 0.140 |
Why?
| Child | 3 | 2019 | 6844 | 0.140 |
Why?
| Osteoclasts | 3 | 2024 | 424 | 0.130 |
Why?
| Predictive Value of Tests | 1 | 2019 | 907 | 0.130 |
Why?
| Hospital Costs | 1 | 2016 | 72 | 0.130 |
Why?
| Eligibility Determination | 1 | 2016 | 17 | 0.130 |
Why?
| Ceramics | 1 | 2015 | 7 | 0.130 |
Why?
| Computer-Aided Design | 1 | 2016 | 21 | 0.130 |
Why?
| Viscosupplementation | 1 | 2015 | 1 | 0.130 |
Why?
| Hip Dislocation | 1 | 2015 | 17 | 0.130 |
Why?
| Breast Neoplasms | 1 | 2024 | 1183 | 0.130 |
Why?
| Lower Extremity | 3 | 2024 | 92 | 0.130 |
Why?
| Cost-Benefit Analysis | 1 | 2016 | 269 | 0.120 |
Why?
| Weight-Bearing | 1 | 2015 | 46 | 0.120 |
Why?
| Cartilage, Articular | 1 | 2015 | 46 | 0.120 |
Why?
| Biocompatible Materials | 1 | 2015 | 68 | 0.120 |
Why?
| Obesity | 1 | 2023 | 1096 | 0.120 |
Why?
| Treatment Failure | 1 | 2014 | 116 | 0.120 |
Why?
| Patient Selection | 1 | 2016 | 254 | 0.120 |
Why?
| Patient Safety | 1 | 2015 | 102 | 0.110 |
Why?
| Quality Improvement | 1 | 2016 | 205 | 0.110 |
Why?
| Calcium Sulfate | 1 | 2013 | 7 | 0.110 |
Why?
| Staphylococcal Infections | 1 | 2016 | 269 | 0.110 |
Why?
| Motor Activity | 1 | 2014 | 221 | 0.110 |
Why?
| Sex Factors | 1 | 2015 | 691 | 0.110 |
Why?
| Arkansas | 1 | 2019 | 1987 | 0.110 |
Why?
| Staphylococcus aureus | 1 | 2016 | 327 | 0.110 |
Why?
| Body Mass Index | 1 | 2015 | 648 | 0.100 |
Why?
| Age Factors | 1 | 2014 | 1092 | 0.090 |
Why?
| Magnetic Resonance Imaging | 2 | 2016 | 1525 | 0.090 |
Why?
| Outpatients | 2 | 2022 | 112 | 0.090 |
Why?
| Bone Morphogenetic Protein 2 | 1 | 2010 | 46 | 0.080 |
Why?
| Postoperative Period | 2 | 2023 | 170 | 0.080 |
Why?
| Mice | 3 | 2024 | 5658 | 0.080 |
Why?
| Bone Cements | 2 | 2022 | 31 | 0.080 |
Why?
| Inpatients | 2 | 2022 | 193 | 0.080 |
Why?
| Severity of Illness Index | 1 | 2010 | 953 | 0.070 |
Why?
| Prevalence | 2 | 2022 | 956 | 0.060 |
Why?
| Spinal Cord Compression | 1 | 2004 | 10 | 0.060 |
Why?
| Child, Preschool | 1 | 2013 | 3875 | 0.060 |
Why?
| Animals | 3 | 2024 | 13100 | 0.060 |
Why?
| Spinal Neoplasms | 1 | 2004 | 30 | 0.060 |
Why?
| Osteoprotegerin | 1 | 2023 | 52 | 0.050 |
Why?
| Hemangioma | 1 | 2004 | 83 | 0.050 |
Why?
| Knee | 1 | 2023 | 22 | 0.050 |
Why?
| Acute Disease | 2 | 2004 | 367 | 0.050 |
Why?
| Pain Management | 1 | 2024 | 164 | 0.050 |
Why?
| Tumor Microenvironment | 1 | 2024 | 221 | 0.050 |
Why?
| Fracture Fixation, Internal | 1 | 2023 | 39 | 0.050 |
Why?
| Ion Channels | 1 | 2023 | 74 | 0.050 |
Why?
| Transcriptome | 1 | 2024 | 312 | 0.050 |
Why?
| Pelvis | 1 | 2022 | 66 | 0.050 |
Why?
| Femur Neck | 1 | 2021 | 6 | 0.050 |
Why?
| Synovial Fluid | 1 | 2021 | 16 | 0.050 |
Why?
| Maryland | 1 | 2020 | 32 | 0.050 |
Why?
| New York | 1 | 2020 | 49 | 0.050 |
Why?
| Kentucky | 1 | 2020 | 46 | 0.050 |
Why?
| Florida | 1 | 2020 | 57 | 0.050 |
Why?
| Socioeconomic Factors | 1 | 2023 | 583 | 0.050 |
Why?
| Postural Balance | 1 | 2021 | 56 | 0.050 |
Why?
| Dissociative Disorders | 1 | 2020 | 6 | 0.040 |
Why?
| Research Design | 1 | 2022 | 344 | 0.040 |
Why?
| Cell Line, Tumor | 1 | 2024 | 1388 | 0.040 |
Why?
| Gait | 1 | 2021 | 85 | 0.040 |
Why?
| Cross-Over Studies | 1 | 2021 | 223 | 0.040 |
Why?
| Osteoblasts | 1 | 2023 | 451 | 0.040 |
Why?
| Gene Expression Profiling | 1 | 2024 | 1028 | 0.040 |
Why?
| Bone and Bones | 1 | 2023 | 473 | 0.040 |
Why?
| Chromium Alloys | 1 | 2019 | 6 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2021 | 858 | 0.040 |
Why?
| Mortality | 1 | 2019 | 97 | 0.040 |
Why?
| Reproducibility of Results | 1 | 2022 | 1182 | 0.040 |
Why?
| Morbidity | 1 | 2019 | 128 | 0.040 |
Why?
| Longitudinal Studies | 1 | 2019 | 693 | 0.030 |
Why?
| Muscle, Skeletal | 1 | 2022 | 769 | 0.030 |
Why?
| Awards and Prizes | 1 | 2016 | 18 | 0.030 |
Why?
| Ankle Joint | 1 | 2015 | 22 | 0.030 |
Why?
| Chi-Square Distribution | 1 | 2016 | 275 | 0.030 |
Why?
| Databases, Factual | 1 | 2016 | 660 | 0.030 |
Why?
| Tomography, X-Ray Computed | 1 | 2016 | 1150 | 0.020 |
Why?
| Thoracic Vertebrae | 1 | 2004 | 36 | 0.010 |
Why?
|
|
Stambough's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|